CEP72 and acute lymphoblastic leukemia: An agnostic approach was applied in GWAS, and the results showed that an inherited variant in the promoter region of the CEP72 gene (rs924607, risk genotype TT) was associated with a higher prevalence and severity of VCR-related peripheral neuropathy in children with ALL, during the two years of continuation therapy [58].